EC Healthcare expects a record-high semi-annual sales volume in first half of FY23 of no less than HK$1.8 billion, Represents no less than 17% Y-o-Y increase

Published by
ACN Newswire

Demonstrate a Notable Recovery Trend and Moving Towards New Normal HONG KONG, Oct 17, 2022 – (ACN Newswire) – EC Healthcare (the Company, which together with its subsidiaries is referred to as the Group, SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the Group expects to achieve a record-high semi-annual sales volume from April to September 2022 (the Reporting Period). The demand on medical services provided by the Group remains strong and the Group’s business demonstrate resilience and momentum backed by the Group’s diversified busine…

Read More

See also  Global Membrane Separation Systems Market Report 2021-2024 Major Manufacturers Performance, Market Share and Size (Players: 3M Company, Novasep, Pall Corporation)

Leave a Reply